| KM023 / Kainos Medicine |
| Recruiting | 1 | 46 | | ACC007 tablets 75mg once a day ;ACC007 tablets 150mg once a day ;ACC007 tablets 300mg once a day ;Group A is administrated with single dose after fasting on Day 1 , and single dose after eating on Day 15. ;Group B is administrated with single dose after eating on Day 1 , and single dose after fasting on Day 15. | Beijing You An Hospital, Capital Medical University; Jiangsu Aidea Pharmaceutical.Co., Ltd., Self-financing | Non-nucleoside reverse transcriptase inhibitors, and other antiretroviral drugs in combination with HIV / AIDS. | | | | |
NCT01348516: Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 |
|
|
| Completed | 1 | 83 | RoW | KM-023, Placebo for KM-023 | Kainos Medicine Inc. | Human Immunodeficiency Virus | 03/12 | | | |
ChiCTR1800018007: Clinical Study of Drug- Drug Interaction between ACC007 and (3TC+TDF) |
|
|
| Completed | 1 | 24 | | 300mg once a day oral administration of ACC007 tablets with 75mg specification, subjects in Group A are oral administrated with (3TC 300mg+TDF 300mg) from Day1 to Day17, and with the addition of 300mg ACC007 from Day8 to Day17 ;300mg once a day oral administration of ACC007 tablets with 75mg specification, subjects in Group B are oral administrated with 300mg ACC007 from Day1 to Day17, and with the addition of (3TC 300mg+TDF 300mg) from Day11 to Day17 | Beijing Di Tan Hospital, Capital Medical University; Jiangsu Aidea Pharmaceutical.Co., Ltd., Self-financing | Non-nucleoside reverse transcriptase inhibitors,and other antiretroviral drugs in combination with HIV/AIDS | | | | |
| Completed | 1 | 20 | | 150mg once a day oral administration of ACC007 tablets with 75mg specification for 10 consecutive days ;300mg once a day oral administration of ACC007 tablets with 75mg specification for 10 consecutive days | Beijing You An Hospital, Capital Medical University; Jiangsu Aidea Pharmaceutical Co., Ltd, Self-financing | Non-nucleoside reverse transcriptase inhibitors,and other antiretroviral drugs in combination with HIV/AIDS | | | | |
ChiCTR2000041558: A phase I Study on Absorption,Metabolism and Excretion of [14C] ACC007 in Chinese adult healthy volunteers (Human Material Balance and Biotransformation Research of [14C] ACC007) |
|
|
| Recruiting | 1 | 6 | | Single oral suspension containing 150mg/100μCi [14C] ACC007 | The First Hospital Affiliated of Soochow University; Jiangsu Aidea Pharmaceutical Co., Ltd, Jiangsu Aidea Pharmaceutical Co.,Ltd | Chinese adult healthy volunteers | | | | |
